The worldwide Difficile Infections (Clostridium Difficile Associated Disease) Market is predicted to reach a valuation of US$ 809 Million in 2023, with a CAGR of 6% predicted from 2023 to 2033. Clostridium difficile infection (CDI) is a disease caused by toxic compounds produced by the spore-forming bacteria “Clostridium difficile” found in the intestinal tract. It …
Author Archives: Editor AM
ASEAN Safety Sensors and Switches Market 2022 | Present Scenario and Growth Prospects 2028
The safety sensors and switches market in ASEAN countries is estimated to be worth around US$ 891 Mn in 2022. With rising adoption of ASEAN safety sensors and switches for minimizing the personal and institutional damage, the overall market is anticipated to grow at an impressive CAGR of 10.2% between 2022 and 2028, reaching a valuation of US$ 1.59 Bn by 2028. Safety …
Vessel-Sealing Device Market is dominated by North America | Says FMI Analyst
The market share of Vessel-Sealing Devices is estimated to reach US$ 1,645.90 million in 2023 and the market net worth is forecast to reach over US$ US$ 3,896.44 million by 2033. The global vessel-sealing devices market is expected to register a CAGR of 9%. It has been found that vessel-sealing devices are more effective in …
Continue reading “Vessel-Sealing Device Market is dominated by North America | Says FMI Analyst”
Arterial Cannula Market is expected to garner a market value of US$ 40 Billion by 2032 | FMI
According to a recent FMI study, the global Arterial Cannula Market will grow at a 6.6% CAGR from 2022 to 2032. The market is expected to be valued at US$ 40 billion by the end of the assessment period. The rising frequency of chronic diseases necessitating cardiopulmonary bypass surgery (CABG), dialysis, and Extracorporeal Membrane Oxygenation …
Near-Patient Molecular Solutions Market is expected to be worth US$ 7.56 billion by 2033 | FMI Study
The Near-Patient Molecular Solutions Market is estimated to register a magnificent CAGR of 8% during the forecast period. According to FMI, the market is projected at US$ 7.56 Billion by 2033, up from US$ 3.5 Billion in 2023. The increasing prevalence of diseases such as diabetes and cardiac diseases is increasing the adoption of near-patient molecular solutions for effective treatment during the forecast …
Intradermal Injection Market is expected to be reach a valuation of US$10814.47 million by 2032 | FMI
The Global Intradermal Injection Market is expected to surpass an impressive valuation of US$ 3,878 Million in 2022, with a compound annual growth rate (CAGR) of 10.8% from 2022 to 2032. In recent years, technological advancements have led to the development of surgical approaches with the aim to minimize waste and achieve better results. The …
Hospital Stretchers Market is expected to grow at a CAGR of around 5.7% by 2032 | FMI
According to a newly released Hospital Stretchers market analysis report by Future Market Insights, global Hospital Stretchers market sales in 2021 will be valued at US$ 2.6 Billion. The projected market growth rate between 2022 and 2032 is 5.7%, which is significantly higher than the historical rate. The absolute dollar opportunity for the Hospital Stretchers …
Asia Pacific Insulin Pump Market is expected to grow at the fastest rate by 2032 | Says FMI Analyst
According to Future Market Insights‘ newly released Insulin Pumps Market analysis report, global sales of the Insulin Pump market in 2021 will be valued at US$ 5 billion. The projected market growth from 2022 to 2032 is 10.3%, which is significantly higher than the historical growth. Because of an aging population, an increase in diabetes …
Pituitary Stalk Interruption Syndrome Treatment Market to Register 3.5% CAGR from 2023 to 2033 | FMI Study
During the forecast period 2023-2033, the Pituitary Stalk Interruption Syndrome Treatment Market is expected to grow at a value of 3.5% CAGR, according to Future Market Insights. By the year 2033, the global market for pituitary stalk interruption syndrome treatment is expected to rise up to a market valuation of US$ 159.14 Million. Growth of …
Oncolytic Virus Cancer Therapy Market is expected to be worth US$ 250 million by 2033 | FMI
According to a recent study published by Future Market Insights, the market for Oncolytic Virus Cancer Therapy is forecast to reach a valuation of US$ 22.86 Million by 2023-end, and will eventually reach US$ 250 Million by 2033, growing at an astronomical CAGR of 27%. Governments in various emerging economies have captured steps to raise …